Skip to main content
UniHealth

Doctor search

Avantika Mundkur, PA

Physician Assistant · Stanford

NPI 1144848565

Medicare standing
2 flags on the record
Listed below.
Plans that list them
Not verified
Not the same as out of network.
Office
1

On the public record

  • California licence: Surrender of License
  • 3 Medical Board actions on record

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Avantika Mundkur’s office at (650) 723-4000 to ask if they take your plan before you enroll.

California Medical Board record

Licence A60364 · Surrendered

Licence status: Surrendered · since 1996 · University of Texas Southwestern Medical School at Dallas. Board flags: Surrender of License, Admin Action By Other State/Fed Gov'T.

Licensee has surrendered his or her license to resolve a disciplinary or licensing action. No practice is permitted.

Matched on the licence number without its letter prefix; check the name before relying on it.

Public record actions

Actions the Medical Board of California publishes for this licence
2011-10-27Action in another state or by a federal agencyDisciplineEffective 03/07/08 indiana board placed dr. treasure on indefinite probation and he was reprimanded. in addition, dr. treasure shall remain compliant with all terms and conditions of dental probation. effective 10/27/2011 probation modified and a fine was assessed. effective 06/27/13 probation terminated. · Indiana health professions bureau
2008-04-21Board disciplineDisciplineSurrender of license. · 16 2008189035
2007-11-30Action in another state or by a federal agencyDisciplineSurrender of texas medical license. · Texas state board of medical examiners

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$5,057

Medicare paid this office $5,057 for 38 people. Most of that is long return visits and Botox.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Long return visit (40+ min)22$3,002$111

Who their Medicare patients are

38 Original Medicare patients in 2024. Average age 69 · Women 53% · Health risk score 2.54. Sicker patients than 9 in 10 peers; the typical physician assistant clinician is at 1.31.

Conditions among them: High blood pressure 53%.

The office billed $19,068, Medicare allowed $6,342 and paid $5,057; for 53 services of 4 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20243853692.54$19,068$5,057
20233857673.52$15,166$5,809
20221425682.79$6,942$2,429

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 1 service

Original Medicare services billed in 2023
Long return visit (40+ min)29$4,446$111

Drugs they prescribed that Part D paid

$82,839

Pharmacies billed $82,839 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

215 generic and fewer than 11 brand-name prescriptions · $82,839 in drug cost · 40 antibiotic prescriptions to 17 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Atovaquone18$6,768$376
Ursodiol11$1,193$108
Acyclovir44$900$20
Sulfamethoxazole-Trimethoprim35$215$6
Pantoprazole17$113$7

Year by year

Part D prescribing by year
202422963NoneNone$82,839
202319150None10%$90,326
202212335NoneNone$17,167

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 4 drugs

Part D drugs prescribed in 2023
Posaconazole17$20,876$1,228
Atovaquone11$3,767$342
Acyclovir56$1,236$22
Sulfamethoxazole-Trimethoprim16$163$10

2022: 1 drug

Part D drugs prescribed in 2022
Acyclovir32$923$29

Money from drug and device companies

$186 in 2025

Industry payments by year
202535None$186
202411None$75
202334None$72

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Astellas Pharma USCresemba$113
2 payments
  • Education · 2025-07-28 · $90
  • Meals for Cresemba · 2025-03-04 · $23
CelgeneBreyanzi$47
2 payments
  • Meals for Reblozyl · 2025-10-07 · $18
  • Meals for Breyanzi · 2025-07-08 · $29
IncyteJakafi$27
1 payment
  • Meals for Jakafi · 2025-01-28 · $27
See all 5 published payments
Every published payment
CelgeneMeals · 2025-10-07Reblozyl$18
Astellas Pharma USEducation · 2025-07-28None$90
CelgeneMeals · 2025-07-08Breyanzi$29
Astellas Pharma USMeals · 2025-03-04Cresemba$23
IncyteMeals · 2025-01-28Jakafi$27
See earlier years (2024, 2023)

2024: $75

Payments by company in 2024
Astellas Pharma USNone$75
1 payment
  • Education · 2024-08-21 · $75

2023: $72

Payments by company in 2023
Kite PharmaYescarta$26
1 payment
  • Meals for Yescarta · 2023-10-03 · $26
Rigel PharmaceuticalsRezlidhia$25
2 payments
  • Meals for Rezlidhia · 2023-10-31 · $23
  • Meals for Rezlidhia · 2023-10-31 · $3
Astellas Pharma USCresemba$21
1 payment
  • Meals for Cresemba · 2023-08-23 · $21

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1144848565
Licence
CA 60364California A60364: Surrendered
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Physician assistant (363A00000X); Student in a training program (390200000X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2020-07-13
NPI last updated
2022-02-07
NPI record certified
2022-02-07

This is when the NPI record was last certified, not a medical board exam.